Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development

Fluvastatin Inhibits Hepatitis C Replication in Humans

(2008) Ted Bader et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors

(2008) J. Paeshuyse et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796

(2008) A. Y. M. Howe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCV

(2008) P MEULEMAN et al.   ANTIVIRAL RESEARCH

The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

(2008) Robert Flisiak et al.   HEPATOLOGY

Targeting Lipid Metabolism in the Treatment of Hepatitis C Virus Infection

(2008) Fumitake Amemiya et al.   JOURNAL OF INFECTIOUS DISEASES